Sign inJoin waitlistJoin the waitlist

TB

Thomas Boyd

Physician · Northwest Medical Specialties Pllc

Credentials: · · · · · ·

History

Northwest Medical Specialties Pllc
2022–Present

Hematology and Medical Oncology
1982–1985
Internal Medicine
1979–1982
SOUTHERN COLL OF MED AND SURG, ATLANTA
1975–1979

Research

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies
Journal of Clinical Oncology · 2013 · 935 citations
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic…
Journal of Clinical Oncology · 2007 · 221 citations
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without…
Journal of Clinical Oncology · 2009 · 121 citations

DR
Donald Richards
4 papers
JS
Jeff Sharman
4 papers
KR
Kanti Rai
4 papers
Bart Scott
3 papers
DS
David Smith
3 papers
Guillermo Garcia-Manero
3 papers
NF
Nathan Fowler
3 papers
Richard Furman
3 papers
Asher Chanan-Khan
2 papers
BS
Barry Skikne
2 papers
BK
Benjamin Koziner
2 papers
Christopher Cogle
2 papers